RE:With all the good news sp keeps goingIt looks like the market place is evenly divided on the prospects for PLI and its medical and scientific innovations.
What do we have to go on to decide for ourselves: yeah, or nay. We can listen to the usually false prophets such as CIBC and other institutional advisors, we can listen to our deranged pumpers, or we can listen to our gut instincts.
Of little help is the fact that a FDA decision has been pending for many months. We don't know what is percolating in their useless minds. They have had an extraordinary amount of time to decide yet continue to dither. They are overly cautious and will err on the side of NO rather than YES.
The track record of PLI doesn't help either. They have never had a drug anywhere at anytime approved. Their track record is near misses only.
My gut says it will be a go, but I don't think it will be this time around. The FDA notoriously plays for time because the decisions they are to make are too complex for them.